[PERSON]
Professor Chloe Orkin
Featured in 1 tracked story · first seen
Situations
Weekly HIV pill trial results
2 clusters · 4 sources · last updated
Latest: Weekly HIV Tablet Matches Daily Regimen in International Trial
In late July, Gilead Sciences and Merck announced that their experimental once‑weekly HIV tablet—combining Merck’s islatravir with Gilead’s lenacapavir—produced undetectable viral loads in two late‑stage trials of adults